0001960394-26-000002.txt : 20260930 0001960394-26-000002.hdr.sgml : 20260930 20260930100413 ACCESSION NUMBER: 0001960394-26-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20260930 DATE AS OF CHANGE: 20260930 EFFECTIVENESS DATE: 20260930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: StemPoint Capital Fund LP CENTRAL INDEX KEY: 0001960394 ORGANIZATION NAME: EIN: 920460297 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-469178 FILM NUMBER: 261425825 BUSINESS ADDRESS: STREET 1: 520 MADISON AVENUE, 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 540-4099 MAIL ADDRESS: STREET 1: 520 MADISON AVENUE, 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D/A 1 primary_doc.xml X0708 D/A LIVE 0001960394 StemPoint Capital Fund LP 520 Madison Avenue, 19th Floor New York NY NEW YORK 10022 (212) 540-4099 DELAWARE None None Limited Partnership true 2022 -- StemPoint Capital GP LLC 520 Madison Avenue, 19th Floor New York NY NEW YORK 10022 Promoter The General Partner of the Issuer. -- StemPoint Capital LP 520 Madison Avenue, 19th Floor New York NY NEW YORK 10022 Promoter The Investment Manager of the Issuer. Michelle Avra Ross c/o StemPoint Capital LP 520 Madison Avenue, 19th Floor New York NY NEW YORK 10022 Executive Officer Managing Member of StemPoint Capital GP LLC, the General Partner of the Issuer. Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0001960394-25-000003 2023-01-01 true true false 50000 Jefferies LLC 2347 Jefferies LLC 2347 520 Madison Avenue New York NY NEW YORK 10022 All States true Indefinite 102450000 Indefinite false 24 0 true 0 0 Customary advisory fees are paid to the Investment Manager on a master fund level as provided for in the Issuer's offering materials. false StemPoint Capital Fund LP /s/ Sean Tan Sean Tan President and Managing Partner 2026-09-30